TURAN, T. Et Al. 2017. Assessment of Vitronectin, Soluble Epithelial-Cadherin and TGF-beta 1 as a Serum Biomarker with Predictive Value for Endometrial and Ovarian Cancers. TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.14, no.2 , 141-147.

TURAN, T., Torun, M., Atalay, F., & GÖNENÇ, A., (2017). Assessment of Vitronectin, Soluble Epithelial-Cadherin and TGF-beta 1 as a Serum Biomarker with Predictive Value for Endometrial and Ovarian Cancers. TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.14, no.2, 141-147.

TURAN, TAYLAN Et Al. "Assessment of Vitronectin, Soluble Epithelial-Cadherin and TGF-beta 1 as a Serum Biomarker with Predictive Value for Endometrial and Ovarian Cancers," TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.14, no.2, 141-147, 2017

TURAN, TAYLAN Et Al. "Assessment of Vitronectin, Soluble Epithelial-Cadherin and TGF-beta 1 as a Serum Biomarker with Predictive Value for Endometrial and Ovarian Cancers." TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.14, no.2, pp.141-147, 2017

TURAN, T. Et Al. (2017) . "Assessment of Vitronectin, Soluble Epithelial-Cadherin and TGF-beta 1 as a Serum Biomarker with Predictive Value for Endometrial and Ovarian Cancers." TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , vol.14, no.2, pp.141-147.

@article{article, author={TAYLAN TURAN Et Al. }, title={Assessment of Vitronectin, Soluble Epithelial-Cadherin and TGF-beta 1 as a Serum Biomarker with Predictive Value for Endometrial and Ovarian Cancers}, journal={TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES}, year=2017, pages={141-147} }